EXOSEAL VASCULAR CLOSURE DEVICE
FDA premarket approval P100013/S009 · decided 2013-05-09
Approval details
- PMA number
- P100013
- Supplement
- S009
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- EXOSEAL VASCULAR CLOSURE DEVICE
- Generic name
- Device, hemostasis, vascular
- Applicant
- Cordis US Corporation
- Date received
- 2013-04-09
- Decision date
- 2013-05-09
- Days to decision
- 30 days
- Decision code
- OK30
- Product code
- MGB
- Advisory committee
- Cardiovascular
- Expedited review
- No
- Location
- Miami Lakes, FL
- Statement
- CHANGE IN THE PROCESSING OF THREE COMPONENTS FROM SINGLE CAVITYMOLD TO MULTI CAVITY MOLDS FOR THE EXOSEAL VASCULAR CLOSURE DEVICE.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.